Teams of researchers from Charité - Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy. It ...

Epileptic activity originating from one or more diseased brain regions in the temporal lobe is difficult to contain. Many patients with so-called temporal lobe epilepsy often do not respond to ...

Temporal lobe epilepsy is a chronic neurologic disorder and is the most common form of focal epilepsy with more than 600,000 individuals suffering from the disorder in the United States. Approximately ...

SAN FRANCISCO – African Americans are less than half as likely as non-Hispanic whites to undergo surgery for temporal lobe epilepsy, according to research that will be presented at the American ...

Successful surgeries in Pakistan highlight early intervention and multidisciplinary care for drug-resistant epilepsy ...

In temporal lobe epilepsy — a common and debilitating form of the disorder — seizures often cause those affected to lose consciousness. But why that happens has been unclear. In a new study, Yale ...

December 5, 2008 — A new analysis using a simulation model suggests that, on average, anterior temporal-lobe resection should provide substantial gains both in life expectancy and quality of life for ...

For patients with mesial temporal lobe epilepsy (MTLE) that can't be controlled by medications, a minimally invasive laser procedure performed under MRI guidance provides a safe and effective ...

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from ...

Grafting autologous medial ganglionic eminence (MGE) cells may ultimately open the door to alleviating spontaneous recurrent seizures — and potentially provide permanent, patient-specific treatment of ...

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from ...

LEXINGTON, Mass. and AMSTERDAM, Nov. 21, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...